XORTX Files U.S. FDA Pre-IND Meeting Request for XRx-101 (Oxypurinol) COVID-19 Program and Pre-IND Meeting Submission
● Potential of Acute Kidney Injury Emerging as a Serious Consequence of COVID-19 ● […]
● Potential of Acute Kidney Injury Emerging as a Serious Consequence of COVID-19 ● […]
Expansion of patents granted to The University of Texas System on behalf of M. D. Anderson Cancer Center […]
Dr. David Sans stated, “With forty million Americans living with kidney diseases and 700,000 having kidney failure, millions of lives are impacted by kidney-related illnesses. […]
● Exploring Elevated Uric Acid in Acute Kidney Injury from COVID-19 ● […]
Whitehorse, YT / July 27, 2020 / Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”), is pleased to announce a major safety accomplishment exceeding two years without a Lost Time Incident (“LTI”) at the Eagle […]
– Pulmonology opinion leaders in ARDS therapies will bring invaluable insight in Company’s clinical trial design CRANFORD, N.J., July 22, 2020 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“CITIUS”) (“Company”) (NASDAQ: CTXR), a specialty pharmaceutical company focused on developing and […]
Significantly Strengthened Balance Sheet through Recent Capital Raises and Debt Reduction
Launched COVID-19 Testing at JFK International Airport on June 22nd
Files SEC Form 10-Q for the First Quarter ending March 31, 2020 […]
Whitehorse, YT / July 1, 2020 / Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”) is pleased to provide an update regarding commercial production and Covid-19 protocols as production continues at the Eagle Gold Mine […]
– FDA provides very specific guidelines to study iPSC-derived MSCs – Company intends to submit an IND application for its iMSC therapy for patients with ARDS associated with COVID-19 CRANFORD, N.J., June 26, 2020 /PRNewswire/ […]
PRINCETON, N.J., June 24, 2020 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com